Despite the difficulties related to the COVID-19 pandemic and lockdown measures, QISTA continues its international development. Particularly in countries where mosquitoes, much more than COVID-19, represent a serious public health problem because they are vectors of diseases such as malaria or dengue fever.
QISTA, the young French company developing an innovative mosquito control solution by using biomimicry, inaugurated the MoniPrev project at the El Hajji Ibrahima Niasse regional hospital in Kaolack – one of the largest cities in Senegal – last Saturday, October 31, in the presence of Mr. Oumar Gueye (Minister of Local Authorities, Regional Planning and Development) and Mr. Philippe Lalliot, Ambassador of France to Senegal.
In 2019, among 226 companies, QISTA won the call for projects “Innovative Solutions for Sustainable Cities in Africa”, financed by the French Treasury. This in the perspective of the Africa-France 2020 summit, initially scheduled to take place in Bordeaux on 4, 5 and 6 June 2020 and currently being rescheduled for 2021.
QISTA has just installed a total of 104 mosquito traps in the Kaolack Regional Hospital, but also around schools, medical centres and other public spaces in the department. The mission is twofold: to protect areas infested by malaria and to monitor potential areas of mosquito proliferation. A project carried out alongside the PNLP (National Malaria Control Programme) which is trying to find effective solutions in order to meet the objective of 0 malaria in Senegal by 2030.
While all eyes are on Covid-19, vector-borne diseases transmitted by mosquitoes (malaria, dengue fever, Zika, chikungunya…) are more fatal overall, having for a long time been responsible for at least 830,000 deaths1 worldwide each year.
To read the entire press release :
About Techno BAM and QISTA
Created in 2014 and based in Aix-en-Provence, Techno BAM specialises in eco-responsible mosquito control and vector prevention. It currently employs around forty people and has a turnover of €2 million in 2019. The company, created by Pierre Bellagambi and Simon Lillamand, has developed the QISTA solution, a mosquito control device using an ecological trap that protects against bites but also enables mosquito populations to be monitored for the purpose of preventing the diseases they may carry. Air Liquide, France Industrie and TDH (Thierry Dassault Holding) acquired a stake in the French start-up in 2017. In 2018, QISTA was awarded at the CES in Las Vegas. Today, QISTA is present in more than 40 municipalities in 13 countries, with a total of more than 5,000 traps installed.
For more information: https://qista.com/en/ and @qista_technobam
![](https://frenchhealthcare-association.fr/wp-content/uploads/2020/11/Qista-4-576x1024.jpg)
![](https://frenchhealthcare-association.fr/wp-content/uploads/2020/11/Qista-3.jpg)